Superworth

GeneDx profit margin WGS

Gross, operating and net profit as a share of revenue over the last twelve months, from 2022.

Net margin, 12 months
−23.4%
Operating margin, 12 months
−20.3%
Net margin on a year earlier
−23.8 pts
Peer median
5.0%

Over the twelve months to Jun 30, 2026, GeneDx kept −23.4% of its revenue as net profit, with an operating margin of −20.3% and a gross margin of 69.4%.

The median for 10 hospital and care facility stocks of a similar size is 5.0%.

Profit margin over time

GrossOperatingNet

Open the interactive chart, with overlays and comparisons

Fiscal year by fiscal year

Fiscal yearNet marginOperating marginGross margin
FY2025−4.9%−3.1%69.7%
FY2024−17.1%−7.6%63.6%
FY2023−86.8%−89.2%44.4%
FY2022n/an/a−11.4%
FY2021n/an/a−7.8%
FY2020n/an/a2.2%

Quarter by quarter

QuarterEndedNet margin, 12 monthsChange on a yearOperating margin
Q2 FY26−23.4%−23.8 pts−20.3%
Q1 FY26−17.6%−5.9 pts−14.9%
Q4 FY25−4.9%+12.2 pts−3.1%
Q3 FY250.5%+31.8 pts2.5%
Q2 FY250.4%+48.6 pts1.5%
Q1 FY25−11.7%+49.2 pts−4.3%
Q4 FY24−17.1%+69.7 pts−7.6%
Q3 FY24−31.2%n/a−21.6%
Q2 FY24−48.2%n/a−38.1%
Q1 FY24−60.9%n/a−60.4%
Q4 FY23−86.8%n/a−89.2%
Q3 FY23n/an/an/a

Against its peers

Companies in Medical - Care Facilities nearest GeneDx's size, closest first, today.

CompanyProfit margin
WGSGeneDx−23.4%
ARDTArdent Health1.2%
HCSGHealthcare Services6.6%
PNTGPennant2.9%
USPHU S Physical Therapy4.0%
PGNYProgyny6.0%
ADUSAddus HomeCare7.1%
MDPediatrix Medical9.0%
OMDAOmada Health1.4%
PRVAPrivia Health1.2%
AVAHAveanna Healthcare10.6%
Peer median5.0%

Where GeneDx ranks

What the profit margin tells you

Profit as a share of revenue at three levels: gross (after making the product), operating (after running the business) and net (after everything, including tax and interest).

Compare within an industry. 10% is superb for a retailer and poor for a software company.

More on GeneDx

Valuation data, not investment advice. Prices as of . Reported figures come from the company's filings with the SEC.